156 related articles for article (PubMed ID: 38650367)
1. Histopathological tumour microenvironment score independently predicts outcome in primary operable colorectal cancer.
Hatthakarnkul P; Pennel K; Alexander P; van Wyk H; Roseweir A; Inthagard J; Hay J; Andersen D; Maka N; Park J; Roxburgh C; Thuwajit C; McMillan D; Edwards J
J Pathol Clin Res; 2024 May; 10(3):e12374. PubMed ID: 38650367
[TBL] [Abstract][Full Text] [Related]
2. The relationship between tumour budding, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
van Wyk HC; Park JH; Edwards J; Horgan PG; McMillan DC; Going JJ
Br J Cancer; 2016 Jul; 115(2):156-63. PubMed ID: 27299960
[TBL] [Abstract][Full Text] [Related]
3. The Relationship Between Tumor Budding, Tumor Microenvironment, and Survival in Patients with Primary Operable Colorectal Cancer.
van Wyk HC; Roseweir A; Alexander P; Park JH; Horgan PG; McMillan DC; Edwards J
Ann Surg Oncol; 2019 Dec; 26(13):4397-4404. PubMed ID: 31605345
[TBL] [Abstract][Full Text] [Related]
4. The relationship between tumour stroma percentage, the tumour microenvironment and survival in patients with primary operable colorectal cancer.
Park JH; Richards CH; McMillan DC; Horgan PG; Roxburgh CSD
Ann Oncol; 2014 Mar; 25(3):644-651. PubMed ID: 24458470
[TBL] [Abstract][Full Text] [Related]
5. Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer.
Park JH; van Wyk H; Roxburgh CSD; Horgan PG; Edwards J; McMillan DC
Br J Cancer; 2017 May; 116(11):1444-1450. PubMed ID: 28427085
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of a tumor microenvironment-based prognostic score in primary operable colorectal cancer.
Park JH; McMillan DC; Powell AG; Richards CH; Horgan PG; Edwards J; Roxburgh CS
Clin Cancer Res; 2015 Feb; 21(4):882-8. PubMed ID: 25473000
[TBL] [Abstract][Full Text] [Related]
7. Combined epithelial marker analysis of tumour budding in stage II colorectal cancer.
Slik K; Blom S; Turkki R; Välimäki K; Kurki S; Mustonen H; Haglund C; Carpén O; Kallioniemi O; Korkeila E; Sundström J; Pellinen T
J Pathol Clin Res; 2019 Jan; 5(1):63-78. PubMed ID: 30358171
[TBL] [Abstract][Full Text] [Related]
8. The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer.
Gujam FJ; Edwards J; Mohammed ZM; Going JJ; McMillan DC
Br J Cancer; 2014 Jul; 111(1):157-65. PubMed ID: 24874480
[TBL] [Abstract][Full Text] [Related]
9. The association between markers of tumour cell metabolism, the tumour microenvironment and outcomes in patients with colorectal cancer.
Roseweir AK; Clark J; McSorley ST; vanWyk HC; Quinn JA; Horgan PG; McMillan DC; Park JH; Edwards J
Int J Cancer; 2019 May; 144(9):2320-2329. PubMed ID: 30521130
[TBL] [Abstract][Full Text] [Related]
10. Tumour budding is associated with the mesenchymal colon cancer subtype and RAS/RAF mutations: a study of 1320 colorectal cancers with Consensus Molecular Subgroup (CMS) data.
Trinh A; Lädrach C; Dawson HE; Ten Hoorn S; Kuppen PJK; Reimers MS; Koopman M; Punt CJA; Lugli A; Vermeulen L; Zlobec I
Br J Cancer; 2018 Nov; 119(10):1244-1251. PubMed ID: 30385823
[TBL] [Abstract][Full Text] [Related]
11. Microenvironment, systemic inflammatory response and tumor markers considering consensus molecular subtypes of colorectal cancer.
Jakab A; Patai ÁV; Darvas M; Tormássi-Bély K; Micsik T
Pathol Oncol Res; 2024; 30():1611574. PubMed ID: 38645565
[No Abstract] [Full Text] [Related]
12. Prognostic effects of histology-based tumour microenvironment scores in resected distal bile duct cancer.
Hwang HW; Kim JY; Lee SE; Choi YS; Hong SH; Lee TJ; Kim MK; Park ES; Hong SA
Histopathology; 2020 Sep; 77(3):402-412. PubMed ID: 32473032
[TBL] [Abstract][Full Text] [Related]
13. Utility of Glasgow Microenvironment Score as a prognostic tool in colorectal carcinoma.
Ahuja M; Dwarak A; Mallya V; Mandal S; Tomar R; Khurana N; Lal P; Singh K
J Cancer Res Ther; 2023 Apr; 19(Supplement):S172-S176. PubMed ID: 37147995
[TBL] [Abstract][Full Text] [Related]
14. Tumor Budding in Colorectal Carcinoma Showing a Paradoxical Mitotic Index (Via PHH3) With Possible Association to the Tumor Stromal Microenvironment.
Hacking S; Sajjan S; Angert M; Ebare K; Jin C; Chavarria H; Kataria N; Zhang L; Cho M; Thomas R; Lee L; Nasim M
Appl Immunohistochem Mol Morphol; 2020 Sep; 28(8):627-634. PubMed ID: 31567276
[TBL] [Abstract][Full Text] [Related]
15. Peritumoral tertiary lymphoid structure and tumor stroma percentage predict the prognosis of patients with non-metastatic colorectal cancer.
Wang Q; Shen X; An R; Bai J; Dong J; Cai H; Zhu H; Zhong W; Chen W; Liu A; Du J
Front Immunol; 2022; 13():962056. PubMed ID: 36189233
[TBL] [Abstract][Full Text] [Related]
16. The relationship between phosphorylation status of focal adhesion kinases, molecular subtypes, tumour microenvironment and survival in patients with primary operable ductal breast cancer.
Andisha NM; McMillan DC; Gujam FJA; Roseweir A; Edwards J
Cell Signal; 2019 Aug; 60():91-99. PubMed ID: 30981841
[TBL] [Abstract][Full Text] [Related]
17. The Glasgow Microenvironment Score and risk and site of recurrence in TNM I-III colorectal cancer.
Alexander PG; van Wyk HC; Pennel KAF; Hay J; McMillan DC; Horgan PG; Roxburgh CSD; Edwards J; Park JH
Br J Cancer; 2023 Feb; 128(4):556-567. PubMed ID: 36476660
[TBL] [Abstract][Full Text] [Related]
18. An immune, stroma, and epithelial-mesenchymal transition-related signature for predicting recurrence and chemotherapy benefit in stage II-III colorectal cancer.
Cai D; Wang W; Zhong ME; Fan D; Liu X; Li CH; Huang ZP; Zhu Q; Lv MY; Hu C; Duan X; Wu XJ; Gao F
Cancer Med; 2023 Apr; 12(7):8924-8936. PubMed ID: 36629124
[TBL] [Abstract][Full Text] [Related]
19. Back to the future: routine morphological assessment of the tumour microenvironment is prognostic in stage II/III colon cancer in a large population-based study.
Hynes SO; Coleman HG; Kelly PJ; Irwin S; O'Neill RF; Gray RT; McGready C; Dunne PD; McQuaid S; James JA; Salto-Tellez M; Loughrey MB
Histopathology; 2017 Jul; 71(1):12-26. PubMed ID: 28165633
[TBL] [Abstract][Full Text] [Related]
20. Comparison of visual and automated assessment of tumour inflammatory infiltrates in patients with colorectal cancer.
Forrest R; Guthrie GJ; Orange C; Horgan PG; McMillan DC; Roxburgh CS
Eur J Cancer; 2014 Feb; 50(3):544-52. PubMed ID: 24332571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
